Profile data is unavailable for this security.
About the company
Apex Healthcare Berhad is a Malaysia-based healthcare company. The Company is focused on the development, manufacturing, wholesaling, marketing and distribution of pharmaceuticals, consumer healthcare products, and medical devices. It operates through three segments: Manufacturing, Distribution and Corporate. It is engaged in the manufacturing of pharmaceutical products. It is involved in the distribution of pharmaceutical and healthcare products. The Corporate segment comprises investments, properties and others. It is also engaged in the contract manufacturing of orthopedic devices. Its brands include XEPATM, AVO, AGNESIA, AEVA and HENNSON, and products bearing these brands are sold in approximately 16 territories worldwide. The Company's distribution channels reach hospitals, clinics, independent and chain pharmacies, supermarkets and health stores, enabling products to reach customers, namely doctors, pharmacists, nutritionists, retailers, and ultimately the patients or consumers.
- Revenue in MYR (TTM)938.55m
- Net income in MYR394.92m
- Incorporated1998
- Employees976.00
- LocationApex Healthcare Bhd1-5 Jalan TTC 1, Cheng Industrial EstateMALACCA 75250MalaysiaMYS
- Phone+60 63370980
- Fax+60 63370570
- Websitehttp://www.apexhealthcare.com.my/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nihon Chouzai Co Ltd | 10.21bn | 76.61m | 1.34bn | 5.69k | 16.84 | 0.7368 | 3.84 | 0.1311 | 85.34 | 85.34 | 11,375.31 | 1,950.41 | 1.79 | 7.62 | 15.53 | -- | 1.34 | 2.27 | 2.34 | 3.94 | 16.82 | 17.26 | 0.7502 | 1.40 | 0.6239 | 25.75 | 0.4849 | 17.87 | 8.61 | 6.73 | -42.73 | -7.60 | 12.04 | 0.00 |
Dingdang Health Technology Group Ltd | 3.16bn | -146.86m | 1.35bn | 2.62k | -- | 1.02 | -- | 0.4277 | -0.1819 | -0.1819 | 3.91 | 1.64 | 1.53 | 5.48 | 44.37 | 2,002,890.00 | -7.26 | -55.91 | -10.34 | -82.51 | 31.10 | 32.74 | -4.75 | -35.83 | 1.93 | -- | 0.0644 | -- | 12.19 | 52.72 | 92.03 | -- | 13.40 | -- |
Shanghai No.1 Pharmacy Co Ltd | 1.19bn | 62.26m | 1.59bn | 870.00 | 25.52 | 2.35 | -- | 1.34 | 0.429 | 0.429 | 8.17 | 4.65 | 0.922 | 4.57 | 7.96 | 2,094,816.00 | 4.84 | 5.42 | 8.10 | 8.94 | 18.34 | 19.04 | 5.25 | 4.64 | 1.18 | -- | 0.2272 | 30.93 | -31.49 | 9.11 | -37.81 | 13.60 | 8.75 | 13.97 |
Yakuodo Holdings Co Ltd | 4.27bn | 114.78m | 1.66bn | 978.00 | 14.36 | 1.65 | 8.33 | 0.389 | 195.20 | 195.20 | 7,259.05 | 1,700.13 | 2.05 | 4.85 | 87.88 | 145,440,700.00 | 5.52 | 5.54 | 8.43 | 8.67 | 21.57 | 22.40 | 2.69 | 2.72 | 0.3559 | 168.03 | 0.2898 | 14.35 | 10.44 | 9.15 | 18.02 | 5.37 | -15.28 | 4.36 |
Qol Holdings Co Ltd | 5.40bn | 146.44m | 1.74bn | 5.75k | 11.37 | 1.05 | 7.58 | 0.3219 | 131.08 | 131.08 | 4,837.03 | 1,414.42 | 1.64 | 30.00 | 10.64 | -- | 4.44 | 4.70 | 6.76 | 7.45 | 12.91 | 13.29 | 2.71 | 2.83 | 1.22 | -- | 0.3745 | 22.79 | 5.89 | 4.46 | -13.72 | 4.54 | 7.04 | 1.39 |
Apex Healthcare Berhad | 938.55m | 394.92m | 2.04bn | 976.00 | 5.14 | 2.16 | 4.94 | 2.18 | 0.5521 | 0.5521 | 1.31 | 1.32 | 0.9744 | 5.76 | 4.61 | 961,629.10 | 41.00 | 19.28 | 50.72 | 24.62 | 22.91 | 22.06 | 42.08 | 16.80 | 3.17 | -- | 0.0096 | 19.79 | 6.66 | 7.48 | 294.15 | 46.70 | -16.11 | 17.32 |
Cawachi Ltd | 8.58bn | 141.43m | 2.06bn | 2.77k | 13.26 | 0.5607 | 7.62 | 0.2402 | 210.78 | 210.78 | 12,788.75 | 4,983.15 | 1.46 | 6.50 | 33.52 | -- | 2.41 | 2.57 | 3.54 | 3.82 | 23.01 | 22.57 | 1.65 | 1.76 | 0.8316 | 580.38 | 0.1307 | 24.45 | 1.45 | 1.47 | 12.83 | 18.51 | 14.19 | 12.20 |
HPGC Renmintongtai Pharmaceutical Corp | 6.72bn | 194.31m | 2.46bn | 2.96k | 12.64 | 1.33 | -- | 0.3653 | 0.5151 | 0.5151 | 17.82 | 4.88 | 1.43 | 9.31 | 2.43 | 3,491,425.00 | 4.12 | 3.98 | 10.51 | 10.87 | 9.30 | 10.60 | 2.89 | 2.73 | 1.33 | 24.63 | 0.4598 | 12.28 | 7.77 | 8.05 | 10.47 | 2.53 | 32.58 | -- |
Genky DrugStores Co Ltd | 5.44bn | 177.26m | 2.60bn | 1.75k | 14.39 | 1.90 | 7.67 | 0.4773 | 388.53 | 388.53 | 11,933.87 | 2,948.95 | 1.74 | 6.69 | 51.56 | 103,503,100.00 | 5.68 | 4.61 | 8.63 | 7.40 | 20.31 | 21.18 | 3.26 | 2.81 | 0.349 | 92.80 | 0.4136 | 9.76 | 9.32 | 12.25 | 7.77 | 8.85 | 13.42 | 14.87 |
Sipai Health Technology Co, Ltd | 3.06bn | -166.34m | 2.82bn | 3.10k | -- | 2.67 | -- | 0.9194 | -0.3551 | -0.3551 | 6.67 | 2.29 | 1.64 | 16.33 | 11.84 | 1,641,316.00 | -8.59 | -- | -13.95 | -- | 8.80 | -- | -5.24 | -- | 1.92 | -- | 0.0398 | -- | 14.39 | -- | 81.34 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Public Mutual Bhd.as of 15 Mar 2023 | 11.94m | 1.66% |
Capital Dynamics Asset Management Sdn. Bhd.as of 15 Mar 2023 | 3.75m | 0.52% |
Manulife Investment Management (M) Bhd.as of 15 Mar 2023 | 1.53m | 0.21% |
Phillip Capital Management Sdn. Bhd.as of 31 Dec 2023 | 177.30k | 0.03% |
Dimensional Fund Advisors LPas of 09 May 2024 | 148.95k | 0.02% |
BOS Wealth Management Malaysia Berhadas of 31 Dec 2023 | 75.00k | 0.01% |
FIL Investments Internationalas of 30 Jun 2023 | 43.35k | 0.01% |
Dimensional Fund Advisors Ltd.as of 31 Mar 2024 | 22.24k | 0.00% |